View the 2024 AAO Report to learn how managed care pharmacy professionals facilitate appropriate access to prescription treatments and promote affordability to help improve outcomes for patients across America’s health care system.
On October 2, 2024, the Centers for Medicare & Medicaid Services (CMS) and the Department of Health and Human Services (HHS) issued the Final Guidance for the Second Cycle of the Historic Medicare Drug Price Negotiation Program for Fiscal Year 2027.
On Oct. 1, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a set of frequently asked questions (FAQs) related to the Medicare Prescription Payment Plan.
In this video, Sandy from North Carolina shares her health journey with alopecia, an autoimmune condition that causes hair loss.
In this video, Sean Riley from New Hampshire shares his health journey with amyloidosis, a rare genetic condition caused by mutations in certain genes that lead to the abnormal production of amyloid proteins.
On September 30, 2024, the Centers for Medicare and Medicaid Services (CMS) issued a Decision Memo titled “Final National Coverage Determination (NCD) for Pre-Exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention”
In this video, Bethany from Ohio shares her health journey with schizophrenia and depression, and side effects from going off her medication. She spent a year trying different anti-psychotic medications.
Now Available: Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy Report 2024. On Oct. 10, AMCP unveiled the 2024 edition of Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy report.
On Sept. 20, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a final rule on the Medicare Drug Rebate Program (MDRP). Access the Regulatory NewsBREAK to learn more.
Get quick answers to some of the most common questions on GLP-1 therapies. Get quick answers to some of the most common questions on GLP-1 therapies. Explore how these treatments fit into managed care pharmacy and the nuances of managing this class.
